Angle closure glaucoma complicating systemic atropine use in the cardiac catheterization laboratory.
Atropine may precipitate angle closure glaucoma in those predisposed to the disorder. Previously reported cases demonstrate the frequent misdiagnosis of acute glaucoma as conjunctivitis. Resultant delays in treatment can lead to vision loss. The present case describes a 66-yr-old man who developed acute angle closure glaucoma after receiving atropine during a coronary angioplasty produce. Clinicians who utilize atropine should be aware of the possibility of precipitating angle closure glaucoma and the predisposing factors, signs, and symptoms to facilitate prompt diagnosis and treatment of this disorder.
Mandak
J S
JS
Department of Cardiology, Geisinger Medical Center, Danville, PA 17822-1343, USA.
Minerva
P
P
Wilson
T W
TW
Smith
E K
EK
D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001285:Atropine / Q000009:adverse effects* / Q000627:therapeutic use; D001919:Bradycardia / Q000188:drug therapy; D006328:Cardiac Catheterization; D015812:Glaucoma, Angle-Closure / Q000139:chemically induced*; D006801:Humans; D008297:Male
D000889:Anti-Arrhythmia Agents; D001285:Atropine